| CK-20 | TTF-1 | NSE | S-100 | GrA | SYP | NFP | CD56 | MAP-2 | LCA |
---|
MCC
| + | - | + | - | +/- | +/- | + | + | + | - |
SCLC
| - | + | +/- | - | -/+ | + | -/+ | + | + | - |
MM
| - | - | - | + | - | Â | - | Â | + | - |
LGNEC
| + | Â | + | Â | + | + | -/+ | Â | Â | Â |
Malignant lymphoma
| - | - | - | - | - | Â | -/+ | Â | Â | + |
- + positive, +/- mostly positive, -/+ mostly negative, - negative. CK-20 cytokeratin 20, TTF-1 thyroid transcription factor 1, NSE neuron-spesific enolase, GrA gromogranin A, NFP neurofilament proteins, CD56 neural adhesion molecule, MAP-2 microtubule associated protein 2, LCA leukocyte common antigen SCLC small cell lung carcinoma, MM malignant melanoma, LGNEC low grade neuroendocrine carcinomas